News | Advanced therapies

News

NICE overturns decision on blood cancer treatment elranatamab

Elranatamab is now recommended as a fourth-line treatment for relapsed and refractory multiple myeloma, according to updated guidance from the National Institute for Health and Care Excellence.…

Published: 1 November 2024

News

NICE lifts restrictions on myeloma treatment teclistamab in final draft guidance

The updated guidance recommends the monoclonal antibody for anyone with relapsed or refractory multiple myeloma who has received three or more lines of treatment and whose myeloma has progressed.…

Published: 22 October 2024

News

CAR-T infusions delivered to ‘more than 80’ patients in Wales, says NHS Wales

The NHS Wales Joint Commissioning Committee has enabled 100 patients in Wales to receive an advanced therapy medicinal product to date.…

Published: 21 October 2024

News

More than 1.5 million people could be given tirzepatide for weight loss under NHS proposals

Priority will be given to patients with the highest clinical need, identified as those with a BMI of more than 40 and at least three specific weight-related health problems.…

Published: 8 October 2024

News

NICE rejects cabotegravir for PrEP in draft guidance

Draft guidance said the HIV pre-exposure prophylaxis (PrEP) treatment cabotegravir is not recommended because “it is not possible to determine the cost-effectiveness estimate ... without further analyses from the manufacturer”.…

Published: 30 September 2024

News

More than 2,000 patients tested in UK’s first routine genotyping project for clopidogrel prescribing

Exclusive: The genotyping project at NHS Tayside identified 2,300 patients, 29% of whom emerged as ‘poor’ or ‘intermediate’ CYP2C19-clopidogrel metabolisers.…

Published: 19 August 2024

Opinion

Lessons from testing 2,300 patients at the UK’s first CYP2C19 genotyping system

Specialist clinical pharmacist Alex Matos explains what his team has learned in the two years since setting up the NHS Tayside project to genotype acute stroke patients with an indication for clopidogrel.…

Published: 19 August 2024

Feature

Changes in migraine treatment: how new classes of drugs can provide additional options for patients and prescribers

This episode of The PJ Pod looks at recent changes to National Institute for Health and Care Excellence guidance on the treatment of acute and chronic migraine and what pharmacists should expect from the new class of gepant drugs.…

Published: 2 August 2024

News

NHS rolls out new multiple sclerosis injection that cuts treatment time by 90%

The NHS will be one of the first healthcare systems in the world to offer the new injection in the “coming weeks”.…

Published: 12 July 2024

Feature

‘Beyond weight loss’: what is the future of semaglutide?

As warnings mount around the dangerous accessibility of semaglutide products Wegovy and Ozempic as quick weight loss hacks, researchers are questioning whether the drug has wider implications for other conditions.…

Published: 27 June 2024